These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15929126)

  • 1. Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia.
    Dignani MC; Rex JH; Chan KW; Dow G; deMagalhaes-Silverman M; Maddox A; Walsh T; Anaissie E
    Cancer; 2005 Jul; 104(1):199-204. PubMed ID: 15929126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal immunity and adjuvant cytokine immune enhancement in cancer patients with invasive fungal infections.
    Safdar A
    Clin Microbiol Infect; 2007 Jan; 13(1):1-4. PubMed ID: 17184281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.
    Safdar A
    Bone Marrow Transplant; 2006 Sep; 38(5):327-37. PubMed ID: 16915223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
    Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
    J Infect Dis; 1999 Apr; 179(4):1038-41. PubMed ID: 10068606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
    Page AV; Liles WC
    Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony-stimulating factor and other cytokines in antifungal therapy.
    Roilides E; Farmaki E
    Clin Microbiol Infect; 2001; 7 Suppl 2():62-7. PubMed ID: 11525220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Future directions of antimycotic therapy].
    Meunier F
    Mycoses; 1994; 37 Suppl 2():77-82. PubMed ID: 7541893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficulties with fungal infections in acute myelogenous leukemia patients: immune enhancement strategies.
    Safdar A
    Oncologist; 2007; 12 Suppl 2():2-6. PubMed ID: 18039633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of a generalized human papillomavirus infection with granulocyte-macrophage colony-stimulating factor and interferon gamma immunotherapy in a patient with a primary immunodeficiency and cyclic neutropenia.
    Gaspari AA; Zalka AD; Payne D; Menegus M; Bunce LA; Abboud CN; Tyring SK
    Arch Dermatol; 1997 Apr; 133(4):491-6. PubMed ID: 9126013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of efficacy trials of cytokines in combination with antifungal drugs.
    Kullberg BJ; Oude Lashof AM; Netea MG
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S218-23. PubMed ID: 15546121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes.
    Gil-Lamaignere C; Simitsopoulou M; Roilides E; Maloukou A; Winn RM; Walsh TJ
    J Infect Dis; 2005 Apr; 191(7):1180-7. PubMed ID: 15747255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
    Sachs UJ; Reiter A; Walter T; Bein G; Woessmann W
    Transfusion; 2006 Nov; 46(11):1909-14. PubMed ID: 17076845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children.
    Abzug MJ; Walsh TJ
    Pediatr Infect Dis J; 2004 Aug; 23(8):769-73. PubMed ID: 15295229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular identification of phaeohyphomycosis due to Alternaria infectoria in a patient with acute myeloid leukemia--a case report.
    Leahy TR; Punnett AS; Richardson SE; Gharabaghi F; Wadhwa A
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):318-21. PubMed ID: 19896319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.